• Licensing agreement with Eastech (Huizhou) Co., Ltd. to launch Audeara's hearing technology in China
• Eastech is a Taiwan-listed company valued at over A$350m with expertise in advanced electronics and medical solutions
• Products will be sold under a third-party brand and distributed via leading Chinese e-commerce platforms

Audeara Limited (ASX: AUA), a leading provider of advanced hearing health technology, has entered into a Licensing Agreement with Eastech (Huizhou) Co., Ltd., a wholly owned subsidiary of Eastech Holding Limited (TWSE: 5225), to support the entry of Audeara's proprietary hearing technology into the Chinese medical device market. Under the terms of the agreement, Audeara will provide its proprietary technology and engineering services to Eastech for use in the design and manufacture of hearing devices. The products will be developed under Eastech's NMPA certification and sold via established e-commerce channels in China, including major platforms such as Tmall, JD.com, and Pinduoduo. This strategic relationship enhances the commercial readiness and market reach of the partnership. China represents a substantial long-term growth opportunity for Audeara, with an estimated 426.5 million people affected by hearing loss in 2019, a figure projected to reach 561 million by 2034. The Licensing Agreement has an initial five-year term and Audeara will receive royalties per unit sold, with no minimum purchase obligations.

Audeara sees this as the beginning of a strategic multi-party collaboration that establishes a strong foundation for future product development and commercial growth in China's hearing health market.